Paradigm Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,366
| Closed | -$236K | – | 439 |
|
|
2022
Q1 | $236K | Hold |
3,366
| – | – | 0.06% | 279 |
|
|
2021
Q4 | $324K | Sell |
3,366
-481
| -13% | -$46.4K | 0.08% | 266 |
|
|
2021
Q3 | $334K | Sell |
3,847
-481
| -11% | -$41.8K | 0.09% | 274 |
|
|
2021
Q2 | $354K | Sell |
4,328
-321
| -7% | -$26.3K | 0.09% | 286 |
|
|
2021
Q1 | $442K | Sell |
4,649
-481
| -9% | -$45.7K | 0.12% | 269 |
|
|
2020
Q4 | $318K | Buy |
+5,130
| New | +$318K | 0.09% | 303 |
|
|
2017
Q2 | – | Sell |
-806
| Closed | -$53.2K | – | 622 |
|
|
2017
Q1 | $53.2K | Sell |
806
-1,683
| -68% | -$111K | 0.01% | 569 |
|
|
2016
Q4 | $158K | Sell |
2,489
-4,809
| -66% | -$305K | 0.03% | 315 |
|
|
2016
Q3 | $465K | Sell |
7,298
-1,924
| -21% | -$123K | 0.08% | 263 |
|
|
2016
Q2 | $686K | Buy |
9,222
+160
| +2% | +$11.9K | 0.12% | 156 |
|
|
2016
Q1 | $605K | Sell |
9,062
-3,842
| -30% | -$257K | 0.11% | 194 |
|
|
2015
Q4 | $873K | Sell |
12,904
-2,725
| -17% | -$184K | 0.15% | 123 |
|
|
2015
Q3 | $835K | Buy |
+15,629
| New | +$835K | 0.11% | 201 |
|